Garivulimab
戈瑞沃利单抗
Report date: 2025/07/03 11:04:44
Base Information
Drug NameGarivulimab
Drug Alias Name
Classification
Mechanisms of Action
Targets
Therapy Area/Indications
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/Territory +[4]
CombinationsNo
Global Highest StatusPhase 1 Clinical
Highest Status in ChinaPhase 1 Clinical
Originator CompaniesBeOne Medicines Ltd
China Registration ClassClass 1 therapeutic biologic in China
Develop Information
Active CompaniesBeigene (Guangzhou) Biotechnology Co Ltd
Inactive CompaniesBeOne Medicines Ltd
Active Indications
Inactive Indications
Other Information
ATC CodeN/A
Related LinksN/A